Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy (ASSIAL)

Pfizer

Status: Completed

Conditions: Ankylosing Spondylitis

Treatments: Other: no intervention

Study type: Observational

Funder types: Industry

Identifiers

NCT01856569

B1801362

Details and patient eligibility

About

Observe in real life adherence therapy and time to switch in ankylosing spondylitis patients with predominant assial involvement with 4 anti-TNF.

Full description

retrospective and prospective 150

Enrollment: 152 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

retrospective:12 months at least first anti-TNF therapy prospective: at maximum 6 months observation AS patients with axial involvement

Exclusion criteria

patients in other AS studies involved

Trial design

152 participants in 1 patient group

observational

Treatment:

Other: no intervention